New Frontiers in Heart Failure
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Ashish Shah, MD
Leora Yarboro, MD
Disclosure(s): Arthrex: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 22, 2024)
Presentations
- Richard E. Clark Memorial Paper for Perioperative and Critical Care: The Society of Thoracic Surgeons Intermacs National Database Risk Model for Durable Left Ventricular Assist Device Implantation
Francis D. Pagani, MD, PhD
Disclosure(s): BrioHealth Solutions: Travel (Ongoing)
- Richard E. Clark Memorial Paper Discussant for Perioperative and Critical Care
Robert S.D Higgins, MD, MSHA
- Audience Q&A
- LVAD Support in Patients >75 Years of Age
Arman Kilic, MD
Disclosure(s): 3ive: Consultant (Ongoing); Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing); Abiomed: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing); LivaNova: Consultant (Ongoing), Speaker (Ongoing)
- Are LVAD Patients at a Disadvantage Awaiting Heart Transplantation: Mortality of LVAD Patients on the Waiting List
Ahmet Kilic, MD
- Early Incidence of Cardiac Allograft Vasculopathy in Donation After Circulatory Death Heart Transplantation in the United States
Syed Shahyan Bakhtiyar, MBBS, MBE
- Interhospital Variability in Infections After Durable Left Ventricular Assist Device: Analysis of The Society of Thoracic Surgeons Intermacs Database
Shiwei Zhou, MD
- Is the Increased Utilization of Impella 5.5 Instead of Intra-Aortic Balloon Pump for Bridging Heart Transplant Patients Justified? An Analysis of the UNOS Database
Athanasios Tsiouris, MD, PhD, FACS
- Xenotransplantation in Practice: When Will It be Ready for Primetime?
Bartley P. Griffith, MD
Disclosure(s): Procure On Demand: Owner/Co-Owner Founder/Co-Founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
- Panel Discussion
Available Credit
- 1.50 ABS Accredited CME
- 1.50 ABTS Accredited CME
- 1.50 AMA PRA Category 1 Credit™
Price
Cost:
$0.00
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Ashish Shah, MD
Leora Yarboro, MD
Disclosure(s): Arthrex: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 22, 2024)
Presentations
- Richard E. Clark Memorial Paper for Perioperative and Critical Care: The Society of Thoracic Surgeons Intermacs National Database Risk Model for Durable Left Ventricular Assist Device Implantation
Francis D. Pagani, MD, PhD
Disclosure(s): BrioHealth Solutions: Travel (Ongoing)
- Richard E. Clark Memorial Paper Discussant for Perioperative and Critical Care
Robert S.D Higgins, MD, MSHA
- Audience Q&A
- LVAD Support in Patients >75 Years of Age
Arman Kilic, MD
Disclosure(s): 3ive: Consultant (Ongoing); Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing); Abiomed: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing); LivaNova: Consultant (Ongoing), Speaker (Ongoing)
- Are LVAD Patients at a Disadvantage Awaiting Heart Transplantation: Mortality of LVAD Patients on the Waiting List
Ahmet Kilic, MD
- Early Incidence of Cardiac Allograft Vasculopathy in Donation After Circulatory Death Heart Transplantation in the United States
Syed Shahyan Bakhtiyar, MBBS, MBE
- Interhospital Variability in Infections After Durable Left Ventricular Assist Device: Analysis of The Society of Thoracic Surgeons Intermacs Database
Shiwei Zhou, MD
- Is the Increased Utilization of Impella 5.5 Instead of Intra-Aortic Balloon Pump for Bridging Heart Transplant Patients Justified? An Analysis of the UNOS Database
Athanasios Tsiouris, MD, PhD, FACS
- Xenotransplantation in Practice: When Will It be Ready for Primetime?
Bartley P. Griffith, MD
Disclosure(s): Procure On Demand: Owner/Co-Owner Founder/Co-Founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
- Panel Discussion